#41 of 100 – Healthcare & Pharma

Bupa

International health insurer and healthcare provider, running insurance, clinics, hospitals, dental centres and aged care in 11 core countries.

By Abhimanyu Ghosh, Chairman, WCRC, with the WCRC Business Intelligence Unit · November 2026

Provisional score
WCRC UK's Most Powerful 100 Brands 2026 badge: Bupa #41
Power Score65.92out of 100
UK rank#41 of 100
HeadquartersLondon, England
Founded1947
Latest revenue£18.2bn revenue
Global rankOutside top 100

Bupa in brief

  • Rank: #41 of 100 in UK's Most Powerful 100 Brands 2026; #4 of 5 in Healthcare & Pharma.
  • WCRC Power Score: 65.92 out of 100.
  • Founded: 1947, by Several provident associations and hospital contributory schemes.
  • Owner: The British United Provident Association Limited, London, England.
  • Leadership: Iñaki Ereño, Group Chief Executive Officer.
  • Latest revenue: £18.2bn revenue (FY2025, year to Dec 2025, +11.0%), as per company filings.

What makes Bupa powerful

Bupa is one of Britain's few truly global healthcare brands, and 2025 was a record year for customers. Revenue rose 11% at constant exchange rates to £18.2bn and underlying profit increased 16% to just over £1bn. It now serves 68 million customers, with insurance customers up 14% to 47.1 million and health provision customers up 6% to 20.7 million.

Its model is distinctive. Bupa both insures people and treats them, through clinics, hospitals, dental centres and aged care homes in markets from Australia and Spain to Chile, India and the UK. Having no shareholders means profits are reinvested in healthcare. It opened more than 100 health provision sites in 2025, including new mental health centres, and is growing its digital health services as private medical insurance demand rises in markets such as the UK.

Bupa served 68 million customers in 2025, including 47.1 million insurance customers.

Why Bupa ranks #41

Bupa ranks 41st with a WCRC Power Score of 65.92, just behind Glenfiddich and ahead of Greggs. Its pillars are evenly balanced: positioning and recall (68), trust (66), product and innovation (66) and digital and financial strength (66), the last reflecting record revenue and profit in 2025. Sustainability and governance (62) is its weakest pillar and the main reason it sits in the middle of the ranking.

The Achilles' heel

Bupa's growth depends on managing medical inflation. In the UK, higher claims and commission costs have weighed on insurance profits even as membership rose. Aged care and private healthcare are politically sensitive, exposing the brand to regulatory change and reputational risk in several countries, and any slowdown in demand for private cover would hit its largest markets.

The 2026 story

In March 2026 Bupa reported its 2025 results: revenue up 11% at constant exchange rates to £18.2bn and underlying profit up 16% to just over £1bn, with total customers reaching 68 million. Group chief executive Iñaki Ereño said: "This year we served more customers than ever before." The year saw more than 100 new health provision sites and new mental health centres. Bupa followed with half-year 2026 results in the summer.

Pillar profile

Brand Positioning & Recall (28%)
68
Consumer Trust & Sentiment (26%)
66
Product, Innovation & Delivery (20%)
66
Sustainability, Governance & ESG (16%)
62
Digital Presence & Financial Soundness (10%)
66

Provisional desk scores out of 100, for the WCRC Business Intelligence Unit to validate.

Versus its nearest rivals

Questions people ask

What rank is Bupa in WCRC's UK's Most Powerful Brands 2026?

Bupa ranks #41 of 100 in WCRC's UK's Most Powerful 100 Brands 2026, with a WCRC Power Score of 65.92 out of 100.

What makes Bupa powerful?

Combining insurance with its own health provision lets Bupa serve 68 million customers and reinvest profits, with no shareholders to pay.

What is Bupa's revenue?

£18.2bn revenue (FY2025, year to Dec 2025, +11.0%), as per company filings.

Who founded and owns Bupa?

Bupa was founded in 1947 by Several provident associations and hospital contributory schemes. It is owned by The British United Provident Association Limited and based in London, England.

Who leads Bupa?

Iñaki Ereño, Group Chief Executive Officer.

What is Bupa's biggest challenge?

Rising claims costs and political sensitivity around private healthcare and aged care.

Also featured in

Key facts

BrandBupa
Company / ownerThe British United Provident Association Limited
HeadquartersLondon, England, United Kingdom
Founded1947
Founder(s)Several provident associations and hospital contributory schemes
LeadershipIñaki Ereño, Group Chief Executive Officer
Latest revenue£18.2bn revenue (FY2025, year to Dec 2025, +11.0%), as per company filings
SectorHealthcare & Pharma
Websitebupa.com
Home countryUnited Kingdom

Sources

  • Revenue figure published by The British United Provident Association Limited
  • Company website, official announcements and press releases
  • Published interviews and statements by the leadership
  • WCRC Business Intelligence Unit research: consumer sentiment, ratings and reviews, search demand, media and social data
Want the full picture? For the detailed methodology, a brand's full assessment report, or the parameters behind a score, contact the WCRC Business Intelligence Unit at consulting@wcrcint.com.
For Bupa – badge and citation

Show the badge on your website

WCRC UK's Most Powerful 100 Brands 2026 badge: Bupa #41

Paste the code into your website's HTML. The badge must link back to this page and may not be altered. Download the badge: navy (SVG), white (SVG). For print or high-resolution files, write to consulting@wcrcint.com.

Work with WCRC

Want to go deeper?

The WCRC Business Intelligence Unit can walk you through the research behind this ranking and what it means for your brand, your market or your story.

Contact us: consulting@wcrcint.com

Disclaimer
  1. Who was considered. Only brands whose owners publish financial results were considered. Brands that do not publish their financials have not been assessed or ranked. Not being on this list says nothing about a brand's quality.
  2. Eligibility. Ranked brands generally qualify through UK founding or an owner headquartered in the UK for more than 30 years, together with current UK ownership and control. Dove and Formula 1 are included as classification exceptions. WCRC carries forward the British classification assigned to each in its global 2026 ranking. This classification does not establish that either brand meets the standard UK ownership and control test.
  3. Independent opinion. This ranking is WCRC's independent research and opinion, based on publicly available information as of November 2026. It is not an endorsement of any brand. No brand paid to be included, and inclusion cannot be bought.
  4. Not a valuation. The WCRC Power Score measures brand strength across 50 parameters. It is not a financial valuation of any brand or company, including on the Most Valuable list.
  5. Not advice. Nothing on this site is investment, financial or purchasing advice. Do not rely on it to make decisions of that kind.
  6. Scores. Scores are WCRC's assessment at the time of research. They are opinions, not measurements, and may be revised.
  7. Revenue and facts. Revenue is shown as reported in company filings and published results for the latest available financial year. WCRC has not audited any figure. Facts in the brand articles are checked twice against independent public sources, but errors are possible.
  8. Trademarks. Brand names, logos and trademarks belong to their owners. Their use here is for identification only and does not imply any affiliation with or endorsement by WCRC.
  9. Use of the badge. Ranked brands may use the WCRC badge only as provided, linked to their page, and unaltered. Any other use of the WCRC name, badge or data needs WCRC's written permission.
  10. Rights and AI. © 2026 WCRC. All rights reserved. The WCRC Power Score and its methodology are proprietary. Copying, text and data mining, and use of this content to train artificial intelligence models are not permitted without written permission; WCRC expressly reserves these rights, including under Article 4 of EU Directive 2019/790.
  11. Corrections. To report an error or ask for a review, write to consulting@wcrcint.com. Corrections are made promptly.